Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
about
Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologiesCombination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesCriteria for drugs used in pre-exposure prophylaxis trials against HIV infectionHIV/AIDS epidemiology, pathogenesis, prevention, and treatmentA review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsWhich topical microbicides for blocking HIV-1 transmission will work in the real world?PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesThe microbicide tenofovir does not inhibit nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples.Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transferHuman immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo.Pharmaceutical development of microbicide drug products.In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract.Biomarkers of leukocyte traffic and activation in the vaginal mucosa.
P2860
Q22252604-4464F05A-D507-4FD6-8618-A0EC75D99E4FQ27005602-606A19FC-F875-4043-9277-9BFA9DE4C4AAQ28469067-68BADC01-C7B4-4971-9400-2EF67B6DDE90Q30356074-B34221D1-AD0F-41E7-BEB3-FCB6C0C864CEQ30369008-75E1AC09-CD29-45E9-9D39-5B9BE4E6B650Q33253661-F373F392-F831-4475-8868-D55B668D2A96Q34074331-09E314D4-0315-4EBD-A6F3-C64F91FC3959Q34150951-D24FBEA3-8544-46CC-AAB1-01E2EB1F48C8Q35598601-C3BA67CE-BFBC-446E-AD53-5DF3F2C4399FQ35941408-60FE0B1D-4B0C-428A-9A9B-5D716EA0D734Q36452542-8045F3A0-DA18-4952-9C3F-86A8F8AE4DC0Q36593842-B6830F77-9A59-4E78-ABBD-6E30D275D4FBQ36744775-8C9DF9DB-D9F3-4A4D-9B88-35D943E3F890Q36804032-09AA5A06-7339-4FA2-B1C7-343F9BD80514Q37657468-F3B8FE53-0BA6-495E-ABC7-69908DCD8A28Q39518073-5F62BAC1-269A-4876-BFD9-2D62FBCCD17CQ42280939-6E4F6E26-E1E8-4479-8CB7-48A261B933E5Q51738127-10A7A770-1A80-48A5-9608-E6934C33136D
P2860
Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@ast
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@en
type
label
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@ast
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@en
prefLabel
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@ast
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@en
P356
P1476
Microbicides to prevent HIV tr ...... o chemical barrier protection.
@en
P2093
Darpun Dhawan
Kenneth H Mayer
P356
10.1086/499163
P407
P577
2005-11-17T00:00:00Z